Back

Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stress

11 June 2026 (12:08 - 12:11)
Organised by: Logo
Seminar Presentation Part of: Module B: Mentoring & how-to sessions - Poster rapid fire session 1 Basic Science Open Access Basic Science Course 2026 ESC Fund

About the speaker

Photo
Doctor Noma Assad

Inserm UMR 942- Lariboisiere hospital, Paris (France)

9 More presentations in this session

Presentation thumbnail
Identification of novel epigenetic modulators regulating cardiomyocyte differentiation
Doctor A. Aljagthmi (SA)
Presentation thumbnail
Multi-omics and liquid biopsy approaches for early detection and mechanistic characterization of cancer therapy-related cardiac dysfunction
Doctor M. Camilli (Rome, IT)
Presentation thumbnail
Molecular antagonism between interleukin-6 and the S100A8/A9 heterodimer in the genesis of atrial fibrillation following ST-elevation myocardial infarction: implications for personalised medicine
Mr D. Cozac (Targu Mures, RO)
Presentation thumbnail
Innate-adaptive immune interactions in arrhythmogenic cardiomyopathy
Doctor N. Fabin (Milan, IT)
Presentation thumbnail
Lipin1 protects against vascular dysfunction and neurovascular remodeling after myocardial infarction through regulation of lipid metabolism
Doctor J. Guo (Hangzhou, CN)

Access the full session

Session thumbnail
Module B: Mentoring & how-to sessions - Poster rapid fire session 1

The Event

Event poster

Basic Science Course 2026

11 June 2026 12:08 CET
You may be interested in
thumbnail
Congress Presentation
The source of liberation of dipeptidyl peptidase 3 (DPP3), a newly emerged cardiac biomarker, in pathological situations
20 May 2023
thumbnail
Congress Session
Therapeutic modulation of the immune system in heart failure
18 May 2025
thumbnail
Congress Presentation
High circulating dipeptidyl peptidase 3 is associated with cardiovascular disorders in women with postpartum haemorrhage
12 May 2024
thumbnail
Congress Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources